The added value of advanced neuro-imaging (MR diffusion, perfusion and proton spectroscopy) in diagnosis of primary CNS lymphoma

被引:4
作者
Kayed, Mohamed Hamdy [1 ]
Saleh, Tarek Rashad [1 ]
Reda, Ihab Sami [1 ]
Elsirafy, Mohamed Nasr [1 ]
Farhoud, Ahmed Hafez [1 ]
Abdelzaher, Eman [1 ]
机构
[1] Dept Radiodiag, Alexandria, Egypt
关键词
Primary central nervous system lymphoma; Magnetic resonance imaging; Diffusion weighted images; Perfusion weighted images; Proton magnetic resonance spectroscopy;
D O I
10.1016/j.ajme.2013.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Primary CNS lymphoma is difficult to diagnose with conventional imaging modalities. Magnetic resonance proton spectroscopy, dynamic susceptibility contrast DSC perfusion and diffusion weighted images have been recently investigated as a problem-solving tool for evaluation of primary CNS lymphoma with favorable results. Aim of the work: To assess the value of advanced neuro-imaging (MR diffusion, perfusion and proton spectroscopy) in diagnosis of primary CNS lymphoma. Patients and methods: Five adult patients with suspected primary CNS lymphoma (as suggested by clinical or conventional imaging techniques) were prospectively studied by magnetic resonance proton spectroscopy, dynamic susceptibility contrast DSC perfusion and diffusion weighted images aiming to confirm the suspected diagnosis. The examinations were done on 1.5T machines using diffusion weighted, dynamic susceptibility contrast perfusion and chemical shift CSI imaging sequences. Results: Regarding DWI, all patients show low ADC values ranging from 0.61 to 0.67 +/- 10(-3) mm(2)/s with a mean ADC value of 0.63 +/- 0.025(SD) x 10(-3) mm 2 / s, regarding the DSC perfusion. The max rCBV ratios are ranging from 0.23 to 1.52 with a mean ratio of 1.14 +/- 0.54(SD). Regarding Mthe MRI spectroscopy Cho/Cr ratios are ranging from 1.9 to 63 with a mean ratio of 19.16 +/- 26 (SD), Cho/NAA ratios are ranging from 3.7 to 50 with a mean ratio of 14.8 +/- 19.8, NAA/Cr ratios are ranging from 0.09 to 1.6 with a mean ratio of 0.72 +/- 0.59, NAA/Cho ratios are ranging from 0.02 to 0.3 with a mean ratio of 0.19 +/- 0.1 Lactate peak was found in three cases. Lipid peak was found in two cases. Myo inositol peak was found in one case. Conclusions: Restricted diffusion, relative hypo perfusion, increased Cho/Cr, Cho/NAA, decreased NAA/Cho, NAA/Cr and presence of lactate or lipid peaks are consistent imaging finding in CNS lymphoma. (C) 2013 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 31 条
[11]   Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging [J].
Hartmann, M ;
Heiland, S ;
Harting, I ;
Tronnier, VM ;
Sommer, C ;
Ludwig, R ;
Sartor, K .
NEUROSCIENCE LETTERS, 2003, 338 (02) :119-122
[12]   Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors [J].
Herminghaus, S ;
Pilatus, U ;
Möller-Hartmann, W ;
Raab, P ;
Lanfermann, H ;
Schlote, W ;
Zanella, FE .
NMR IN BIOMEDICINE, 2002, 15 (06) :385-392
[13]   PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - AN UPDATE [J].
JELLINGER, KA ;
PAULUS, W .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 119 (01) :7-27
[14]  
Johnson BA, 1997, AM J NEURORADIOL, V18, P563
[15]   Decreasing incidence rates of primary central nervous system lymphoma [J].
Kadan-Lottick, NS ;
Skluzacek, MC ;
Gurney, JG .
CANCER, 2002, 95 (01) :193-202
[16]   From the archives of the AFIP - Primary central nervous system lymphoma: Radiologic-pathologic correlation [J].
Koeller, KK ;
Smirniotopoulos, JG ;
Jones, RV .
RADIOGRAPHICS, 1997, 17 (06) :1497-1526
[17]   Primary central nervous system lymphomas (PCNSL):: MRI features at presentation in 100 patients [J].
Küker, W ;
Nägele, T ;
Korfel, A ;
Heckl, S ;
Thiel, E ;
Bamberg, M ;
Weller, M ;
Herrlinger, U .
JOURNAL OF NEURO-ONCOLOGY, 2005, 72 (02) :169-177
[18]  
Lanfermann H, 1997, ACTA RADIOL, V38, P259
[19]  
LING SM, 1994, CANCER-AM CANCER SOC, V73, P2570, DOI 10.1002/1097-0142(19940515)73:10<2570::AID-CNCR2820731019>3.0.CO
[20]  
2-1